Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05786287

Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa

Sponsor: PT. Prodia Stem Cell Indonesia

View on ClinicalTrials.gov

Summary

The study will perform to follow-up UC-MSCs and CM transplantation. 18 patients will be called back to be examined after 5 years of UC-MSC and/or CM transplantation.

Official title: Long-term Safety of Umbilical Cord-Mesenchymal Stem Cell (UC-MSC) Transplantation in Patients With Retinitis Pigmentosa

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

OBSERVATIONAL

Enrollment

18

Start Date

2026-05

Completion Date

2027-09

Last Updated

2026-02-25

Healthy Volunteers

No

Interventions

BIOLOGICAL

Conditioned Medium (CM)

Conditioned Medium (CM) injected by peribulbar

BIOLOGICAL

Umbilical Cord Mesenchymal Stem Cell (UC-MSC)

Umbilical Cord Mesenchymal Stem Cell (UC-MSC) injected by peribulbar

Locations (2)

Jakarta Eye Center Hospital

Jakarta, DKI Jakarta, Indonesia

Sardjito Hospital

Yogyakarta, Special Region, Indonesia